The significant gap between the demand for GLP-1s and the ability of users to access them through traditional insurer-mediated distribution channels elevated compounding pharmacies and telehealth companies within the US healthcare landscape as alternative pathways to meet GLP-1 demand
Morley JE, Argiles JM, Evans WJ, Bhasin S, Cella D, Deutz NE, Doehner W, Fearon KC, Ferrucci L, Hellerstein MK, Kalantar-Zadeh K, Lochs H, MacDonald N, Mulligan K, Muscaritoli M, Ponikowski P, Posthauer ME, Rossi FF, Schambelan M, Schols AM, Schuster MW, Anker SD
I think it sends a really terrible message to the public, which just kind of reinstates the stigma around obesity, saying that this is not a disease, this is a choice, she said
The diabetes drug Mounjaro and the obesity shot Zepbound are also facing shortages in certain dosages
Table 3 Studies on the relationship between consumption of contaminated fish and thyroid disorders in humans